We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial
News

ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial

ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial
News

ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ReNeuron Signs Manufacturing Contract to Provide Stem Cells for Stroke Clinical Trial"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Regulatory approval for this trial was granted earlier this year.

Michael Hunt, Chief Executive Officer of ReNeuron, said:
"We are pleased to have extended our collaborative arrangements with Angel by way of this critical manufacturing contract. Angel has proven ability in the manufacture of advanced biologics to the requisite quality standards. As a contract manufacturer based in Scotland, they are also well-placed to serve the needs of ReNeuron's ground-breaking Phase I clinical trial with ReN001 in stroke, to be undertaken at Glasgow's Southern General Hospital once ethics approval has been obtained for the trial.
Advertisement